ArticleOncotarget2017

Targeting the centriolar replication factor STIL synergizes with DNA damaging agents for treatment of ovarian cancer.

Noa Rabinowicz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.